Skip to main content
OpenTrials

Clinical trial condition

Duchenne Muscular Dystrophy

Explore clinical trials studying Duchenne Muscular Dystrophy. Study availability and eligibility vary by location and protocol.

214 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Duchenne Muscular Dystrophy trial results

Recruiting

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

NCT06817382

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • USA012 Little Rock, Arkansas, United States
  • USA010 Davis, California, United States
  • USA009 Los Angeles, California, United States
  • USA002 Palo Alto, California, United States
View Trial Details
Recruiting

Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

NCT05933057

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Universitaire Ziekenhuizen Leuven Leuven, Belgium
  • British Columbia Children's Hospital Vancouver, British Columbia, Canada
  • The University of Western Ontario - Children's Health Research Institute London, Ontario, Canada
  • University of Ottawa - Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada
View all 29 locations
View Trial Details
Recruiting

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

NCT07287189

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DMD, Duchenne, +10 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Colorado Children's Aurora, Colorado, United States
  • Lurie Children's Chicago, Illinois, United States
  • UMass Memorial Medical Center Worcester, Massachusetts, United States
View all 21 locations
View Trial Details
Recruiting

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

NCT06564974

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • Loma Linda University Pediatric Subspecialty Clinics Loma Linda, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

NCT07160634

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Neurology Rare Disease Center Flower Mound, Texas, United States
  • Children's Hospital of the King's Daughters Norfolk, Virginia, United States
  • The Children's Hospital of Westmead Sydney, New South Wales, Australia
View Trial Details
Recruiting

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

NCT06138639

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California, Los Angeles Medical Center Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • University of California San Diego, California, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy

NCT07673809

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Republican Scientific and Practical Center Mother and Child Minsk, Belarus
  • Russian Children's Clinical Hospital Moscow, Russia
  • National Medical Research Center for Children Moscow, Russia
  • Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University Moscow, Russia
View Trial Details
Recruiting

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

NCT04626674

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University Palo Alto, California, United States
  • University of California, Davis Sacramento, California, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details

Related conditions